ABOUT 

Bill Douglass is founder and Managing Principal of Gotham Private Capital. From 2022-’23 he served as a full-time Advisor to Hevolution Foundation, an investor and grantor in the emerging field of healthspan science, with an annual budget of up to $1 Billion. Prior to that, Bill ran Gotham Communications, a strategic communications agency that he founded in 2010. Clients included Ambry Genetics (sold to Konica Minolta for $1 Billion), Advanced Cell Technology (re-branded as Ocata Therapeutics and sold to Astellas Pharma for $379 Million, as covered in The New York Times), and XO1 Ltd. (sold to Janssen Pharma/Johnson & Johnson), as well as family offices, hedge funds, venture capital firms, and real estate private equity firms.

A Registered Representative of Stonehaven, LLC, Member FINRA/SIPC, Bill holds the Uniform Securities Agent license (Series 63) and the Private Securities Offerings Representative license (Series 82). He attended Boston University’s College of Communication and has a BA in Russian Studies with a minor in Russian language from the University of Houston. He has spoken at a variety of conferences, including Reuters’ HedgeWorld, IMN Alpha Hedge West, and the Horasis Global Meeting, and his writings have been published in The Economist and elsewhere.

Having traveled to nearly 70 countries and worked on five continents, and with deep experience in East Asia and the Middle East, Bill has built an international network of contacts. He lives in Fairfield County, Connecticut, outside New York City, with his wife – a practicing physician – and their two young children.